Strides Pharma Science

Strides Pharma Science Market capitalization

The The market capitalization of Strides Pharma Science (STAR.NS) as of Nov 22, 2026 is 79.02 B INR. In the previous year, The market capitalization was 79.02 B INR — a change of 0.00% (lower).

Market capitalization

79.02 BINR

YoY

0.00%

Last updated:

In 2025, Strides Pharma Science's market cap stood at 79.02 B INR, a 0.00% increase from the 79.02 B INR market cap in the previous year.

The Strides Pharma Science Market capitalization history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Market capitalization
Date
Market capitalization
Jan 1, 2018
79.02 B INR
Jan 1, 2019
79.02 B INR
Jan 1, 2020
79.02 B INR
Jan 1, 2021
79.02 B INR
Jan 1, 2022
79.02 B INR
Jan 1, 2023
79.02 B INR
Jan 1, 2024
79.02 B INR
Jan 1, 2025
79.02 B INR
The Strides Pharma Science Market capitalization history
YEARMarket capitalizationYoY
79.02 BINR0.00%
79.02 BINR0.00%
79.02 BINR0.00%
79.02 BINR0.00%
79.02 BINR0.00%
79.02 BINR0.00%
79.02 BINR0.00%
79.02 BINR0.00%
79.02 BINR0.00%
79.02 BINR0.00%
79.02 BINR0.00%
79.02 BINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Strides Pharma Science Stock analysis

What does Strides Pharma Science do? Strides Pharma Science Ltd. generates revenue through the development, manufacturing, and distribution of IP-led generics and bio-pharmaceutical products across its Pharmaceutical and Bio-pharmaceutical segments. The company serves global markets including Africa, Australia, Asia (excluding India), North America, Europe, India, and Others, offering niche pharmaceutical products in various dosage forms such as liquids, creams, ointments, soft gels, sachets, tablets, and modified release formats. Its manufacturing units in Bengaluru, Puducherry, Chennai, Singapore, Milan, Florida, and Nairobi produce anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drugs, alongside soft gelatin capsules. The firm's revenue streams are derived from the sale of its IP-led niche pharmaceutical products to healthcare providers, distributors, and global pharmaceutical companies operating in the specified geographical segments. Key product categories include anti-retroviral, anti-malarial, anti-tuberculosis, and hepatitis treatments, which are distributed through its global manufacturing network. The company's focus on specialized drug segments ensures consistent demand from healthcare systems and institutions managing infectious diseases. Strides Pharma Science Ltd. targets healthcare institutions, distributors, and pharmaceutical companies in regions such as North America, Europe, India, and Africa, where infectious disease management requires specialized treatments. Its manufacturing presence in multiple countries supports direct market access and cost efficiency, enabling the delivery of affordable pharmaceutical solutions. The company's product portfolio emphasizes high-demand therapeutic areas, aligning with global health priorities for infectious disease treatment. Strides Pharma Science is one of the most popular companies on Eulerpool.

Market capitalization Details

Exploring Strides Pharma Science's Market Capitalization

Strides Pharma Science's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Strides Pharma Science's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Strides Pharma Science's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Strides Pharma Science’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Strides Pharma Science stock

The market capitalization of Strides Pharma Science is 79.02 B INR in 2025.

The market capitalization of Strides Pharma Science changed from 79.02 B INR to 79.02 B INR, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The market capitalization Strides Pharma Science since 2006 – with annual values, charts, and detailed analysis.

Market capitalization (German: Market capitalization, English: market capitalisation or market cap) is the calculated total value of all shares of a publicly traded company. The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company. It is determined by the supply and demand for the company's shares. Thus, market capitalization is significantly influenced by expectations in the stock market regarding the future earnings power of the company and, therefore, can be subject to significant fluctuations.

Number of shares * share price = market capitalization

To evaluate The market capitalization's INR, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for The market capitalization.

A 'good' INR varies by industry and company stage. On Eulerpool, you can compare The market capitalization's Strides Pharma Science with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Strides Pharma Science

All Key Metrics — Strides Pharma Science